The European Medicines Agency is to continue accepting applications for its much-discussed adaptive pathways approach for getting drugs for unmet medical needs to market faster, having now completed and reported promising results from its pilot project.
Applicants should bear in mind, however, the hurdles they face in pursuing an adaptive pathways approach, Hilary Jones of law...